Steven J. Berthel

Hoffmann-La Roche 
"Steven Berthel"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Qian Y, Corbett WL, Berthel SJ, et al. (2013) Identification of RO4597014, a Glucokinase Activator Studied in the Clinic for the Treatment of Type 2 Diabetes. Acs Medicinal Chemistry Letters. 4: 414-8
Matschinsky FM, Zelent B, Doliba NM, et al. (2011) Research and development of glucokinase activators for diabetes therapy: theoretical and practical aspects. Handbook of Experimental Pharmacology. 357-401
Deng W, Berthel SJ, So WV. (2011) Intuitive patent Markush structure visualization tool for medicinal chemists. Journal of Chemical Information and Modeling. 51: 511-20
Sarabu R, Berthel SJ, Kester RF, et al. (2011) Novel glucokinase activators: a patent review (2008 - 2010). Expert Opinion On Therapeutic Patents. 21: 13-33
Berthel SJ, Marks IM, Yin X, et al. (2002) Identification of phenyl-pyridine-2-carboxylic acid derivatives as novel cell cycle inhibitors with increased selectivity for cancer cells. Anti-Cancer Drugs. 13: 359-66
Gribble GW, Berthel SJ. (1992) Synthetic Approaches to Indolo[2,3-a]carbazole alkaloids. Syntheses of arcyriaflavin A and AT2433-B aglycone Tetrahedron. 48: 8869-8880
See more...